Skip to content

Effect of LH levels on IVF/ICSI outcomes in antagonist protocols

Effect of LH levels on IVF/ICSI outcomes in antagonist protocols

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097039
Enrollment
Unknown
Registered
2025-02-11
Start date
2025-02-11
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 35 Years

Inclusion criteria

Inclusion criteria: 1. Patients under the age of 35; 2. Patients with high ovarian reserve; 3. Patients with anti-Mullerian hormone (AMH) levels greater than 3.6 µg/L; 4. Patients with flexible GnRH-ant protocol for ovulation induction; 5. Patients with comprehensive clinical data.

Exclusion criteria

Exclusion criteria: 1. Patients who do not meet the diagnostic criteria for ovarian hyperresponsiveness (HOR) population; 2. Patients with clear contraindications to ART; 3. Patients with severe endocrine or metabolic diseases; 4. Patients with related diseases that may affect the outcome of ART, such as untreated severe hydrosalpinx, uterine submucosal fibroids, severe adenomyosis, endometriosis, endometriosis, etc.; 5. Patients with incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Antagonist day LH Level ;Trigger day LH Level ;HCG;Determination of pregnancy outcome;

Secondary

MeasureTime frame
Number of follicles on trigger day;Number of obtained oocytes ;Number of Mature oocytes;Number of normal fertilized oocytes;Number of dipronuclear fertilized eggs;Number of available embryos;Number of high-quality embryos;Number of available blastocysts;Number of high-quality blastocysts;

Countries

China

Contacts

Public ContactWenwu Gui

The First Affiliated Hospital of Chongqing Medical University

guiwenwu023@163.com+86 131 0136 1319

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026